SENZIME AB INVITES TO AN WEBCAST TODAY, JUNE 2 AT 11.00 A.M. CEST

Senzime AB (publ), announced on June 1 that the company has entered into an agreement to acquire the US company Respiratory Motion. Following this announcement, Senzime invites investors, analysts, and media to an webcast (in English) with a Q&A-session on June 2, at 11:00 a.m. CEST.

The presentation will be held by Senzime's CEO Pia Renaudin, Philip Siberg, Chairman of the Board, Jonathan Ekman, Head of M&A and Professor Lars I Eriksson from the section for Anesthesiology and Intensive Care at the Department of Physiology and Pharmacology at Karolinska University Hospital. The webcast will conclude with a Q&A session. No preregistration is required.

Date and time
June 2, 2022, at 11:00 a.m. CEST

Webcast link
https://tv.streamfabriken.com/pressconference-06-2022

The webcast will also be available on demand on Senzime’s corporate website after the event.

Explore our patient monitoring solutions

Get product details

How can Senzime’s products help to eliminate in-hospital complications?
Contact us to discuss your needs or schedule a product demo.